C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2006
12/28/2006	US20060293373 Gamma-secretase inhibitors
12/28/2006	US20060293371 Prodrug and process for producing the same
12/27/2006	EP1736465A1 Aniline derivatives
12/27/2006	EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/27/2006	EP1735287A1 Therapeutic agents
12/27/2006	EP1735275A2 Aryl sulfones and uses related thereto
12/27/2006	EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006	EP1542942B1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis
12/27/2006	EP1358144B1 Epothilone synthesis components i: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone and epothilone derivatives
12/27/2006	EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006	EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006	CN1886421A Hemiasterlin derivatives and uses thereof
12/27/2006	CN1884266A Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/27/2006	CN1291978C Novel crystal form of 5-hydroxy-1-methyl hydantoin
12/26/2006	US7154007 Compounds with perfluoroalkanoacetophenone groups that form complexes with rare earth elements that can be used in immunoassays or nucleic acid assays for labeling a protein, peptide, amino acid, nucleic acid, or nucleotide
12/26/2006	US7153974 Heat and corrosion resistance
12/26/2006	US7153973 Light, heat and oxidation resistance; stabilizers
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153848 13-C5-7-cycloalkylindolo[2.1-a][2]benzazepine derivatives; e.g., 3-[3-[3-[1-[[(13-cyclohexyl-7H-indolo[2,1-a][2]benzazepin-10-yl)carbonyl]amino]cyclopentyl]-1,2,4-oxadiazol-5-yl]phenyl]-(2E)-2-propenoic acid
12/21/2006	WO2006135640A2 Process for the synthesis of organic compounds
12/21/2006	WO2006135619A1 Process for the synthesis of 5- (methyl- 1h-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine
12/21/2006	WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
12/21/2006	WO2006134219A2 Atipamezhole hydrochloride crystallization method
12/21/2006	WO2006133567A1 Helix 12 directed non-steroidal antiandrogens
12/21/2006	WO2006055922A3 Anthranilamide insecticides
12/21/2006	WO2006050002A3 Compositions for controlled delivery of pharmaceutically active compounds
12/21/2006	WO2005080345A3 Imidazoline derivatives having cb1-antagonistic activity
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	US20060287378 Novel pyrroles and imidazoles
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	CA2833394A1 Processes for the synthesis of 5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine and its intermediates
12/21/2006	CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents
12/21/2006	CA2611280A1 Processes for the synthesis of 5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine and its intermediates
12/20/2006	EP1732919A1 Substituted thiophene derivatives as anti-cancer agents
12/20/2006	EP1732901A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
12/20/2006	EP1732898A1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1456171B1 Substituted cyclohexane derivatives
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882588A A2B adenosine receptor antagonists
12/20/2006	CN1882530A Amidines and derivatives thereof and pharmaceutical compositions containing them
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/14/2006	WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors
12/14/2006	WO2006060203A3 Imidazole derivatives for the treatment of dementia and related disorders
12/14/2006	WO2006060202A3 Imidazole derivatives for the treatment of psychiatric disorders
12/14/2006	WO2005100322A8 Sulphur-linked imidazole compounds for the treament of hiv
12/14/2006	US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/14/2006	DE102005025315A1 Ionische Flüssigkeiten mit niedriger Viskosität Ionic liquids with low viscosity
12/13/2006	EP1731510A1 Process for producing n,n'-carbonyldiimidazole
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use
12/13/2006	EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730118A1 Substituted azole derivatives, compositions, and methods of use
12/13/2006	EP1730117A2 Thiourea compositions and uses thereof
12/13/2006	EP1730100A1 Polyamine analogs that activate antizyme frameshifting
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1876635A Method for producing 1,4-dibenzyl -2,3-benzamidine C60
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006	CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289082C Medicine composition for treating diabetes
12/12/2006	US7148371 Method for producing lysine derivative
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148225 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148198 Antibacterial agents
12/12/2006	CA2157753C Processes for producing 1-substituted-2-cyanoimidazole compounds
12/07/2006	WO2006128542A1 Imidazole salts, method for producing them, use thereof and epoxy resins containing said salts
12/07/2006	WO2006010455A3 Salts containing alkoxytris (fluoroalkyl) borate anions
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276517 Non-systemic control of parasites
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276433 Hydrazone derivative
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727804A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
12/06/2006	EP1727541A1 Imidazole-based hmg-coa reductase inhibitors
12/06/2006	EP1727540A1 Melanin-concentrating hormone receptor antagonists and methods of use
12/06/2006	EP1069893B1 Use of dexmedetomidine for icu sedation
12/06/2006	CN1874992A Resolution of 3-amino alkylnitriles
12/06/2006	CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/06/2006	CN1288147C Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/05/2006	US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006	US7145004 Treating a perfluoroalkylphosphorane with an alkaline earth metal hydroxide, an organometallic compound, or an organic base, and optionally treating with an acid in a reaction medium; use as ionic liquids, surfactants or phase-transfer catalysts
12/05/2006	US7144920 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma
12/05/2006	US7144908 Prophylaxis, therapy of respiratory system disorders
12/05/2006	US7144904 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
12/05/2006	US7144900 Pharmaceutical composition
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144876 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/05/2006	CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer

1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 345